Sunesis to Present at Upcoming Investor Conferences
May 14 2014 - 6:00AM
Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that
the company will present at two upcoming investor conferences.
Daniel Swisher, Chief Executive Officer of Sunesis, will present
at the UBS Global Healthcare Conference on Tuesday, May 20, 2014 at
2:00 PM Eastern Time at The Sheraton New York Times Square Hotel in
New York City.
Eric Bjerkholt, Executive Vice President, Corporate Development
and Finance at Sunesis will present at the Jefferies 2014 Global
Healthcare Conference on Tuesday, June 3, 2014 at 3:30 PM Eastern
Time in New York City.
A live webcast of the presentations will be available on the
Sunesis website at http://ir.sunesis.com. A replay of each webcast
will be archived on the "Calendar of Events" page in the Investors
and Media section of the Sunesis website for two weeks.
About Sunesis Pharmaceuticals
Sunesis is a biopharmaceutical company focused on the
development and commercialization of new oncology therapeutics for
the treatment of solid and hematologic cancers. Sunesis has built a
highly experienced cancer drug development organization committed
to advancing its lead product candidate, Qinprezo™ (vosaroxin), in
multiple indications to improve the lives of people with cancer.
For additional information on Sunesis, please visit
http://www.sunesis.com.
For additional information on Sunesis, please visit
http://www.sunesis.com.
CONTACT: Investor and Media Inquiries:
David Pitts
Argot Partners
212-600-1902
Eric Bjerkholt
Sunesis Pharmaceuticals Inc.
650-266-3717
Eliza Schleifstein
Argot Partners
917-763-8106
eliza@argotpartners.com
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Sunesis Pharmaceuticals Inc (NASDAQ): 0 recent articles
More News Articles